This narrative review examines the use of Totally Implantable Venous Access Ports in China for patients needing long-term venous therapy. It covers oncology and other patient groups but does not report specific sample sizes or clinical outcomes. The authors note that the evidence lacks strong uniformity across the region.
The report identifies key challenges in current medical practice. China currently lacks a unified regulatory framework for these devices. There are also no standardized full-lifecycle management protocols in place. Significant disparities exist among medical institutions regarding surgical techniques and complication management.
Safety data regarding adverse events or tolerability were not reported in this review. Because of the noted gaps in regulation and surveillance, patients should be aware that care quality may vary by location. The goal is to provide a reference for optimizing clinical decision-making and improving quality of life.
Readers should understand this is a reference guide rather than a clinical trial proving benefits. It highlights the need for better standardization to minimize adverse events. The document aims to optimize clinical decision-making for providers.